Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Conmed (CNMD) Non-Current Deferred Tax Liability (2016 - 2025)

Historic Non-Current Deferred Tax Liability for Conmed (CNMD) over the last 16 years, with Q4 2025 value amounting to $179.9 million.

  • Conmed's Non-Current Deferred Tax Liability rose 153.19% to $179.9 million in Q4 2025 from the same period last year, while for Dec 2025 it was $179.9 million, marking a year-over-year increase of 153.19%. This contributed to the annual value of $179.9 million for FY2025, which is 153.19% up from last year.
  • Latest data reveals that Conmed reported Non-Current Deferred Tax Liability of $179.9 million as of Q4 2025, which was up 153.19% from $74.9 million recorded in Q3 2025.
  • In the past 5 years, Conmed's Non-Current Deferred Tax Liability ranged from a high of $179.9 million in Q4 2025 and a low of $56.6 million during Q1 2021
  • For the 5-year period, Conmed's Non-Current Deferred Tax Liability averaged around $94.6 million, with its median value being $68.4 million (2023).
  • Its Non-Current Deferred Tax Liability has fluctuated over the past 5 years, first surged by 9100.44% in 2022, then plummeted by 4056.3% in 2023.
  • Quarter analysis of 5 years shows Conmed's Non-Current Deferred Tax Liability stood at $131.3 million in 2021, then increased by 29.8% to $170.4 million in 2022, then fell by 0.14% to $170.2 million in 2023, then grew by 4.11% to $177.2 million in 2024, then grew by 1.53% to $179.9 million in 2025.
  • Its last three reported values are $179.9 million in Q4 2025, $74.9 million for Q3 2025, and $69.8 million during Q2 2025.